Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors

Purpose. To investigate the efficacy and safety of combined vitrectomy with tumor resection in the treatment of retinal vasoproliferative tumors (RVPT). Methods. Retrospective study. RVPT patients who underwent vitreous surgery at the Eye Hospital of Wenzhou Medical University from January 2011 to J...

Full description

Bibliographic Details
Main Authors: Bin Zheng, Yan Chen, Lifeng Chen, Huan Chen, Jingwei Zheng, Feng Chen, Zongming Song, Lin Fu, Xuting Hu, Jiandong Pan, Hengli Lian, Lijun Shen, Qiuming Li
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2019/7464123
id doaj-c1859a106e4641b1acc99f61a50e9c38
record_format Article
spelling doaj-c1859a106e4641b1acc99f61a50e9c382020-11-25T01:25:45ZengHindawi LimitedJournal of Ophthalmology2090-004X2090-00582019-01-01201910.1155/2019/74641237464123Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative TumorsBin Zheng0Yan Chen1Lifeng Chen2Huan Chen3Jingwei Zheng4Feng Chen5Zongming Song6Lin Fu7Xuting Hu8Jiandong Pan9Hengli Lian10Lijun Shen11Qiuming Li12The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, ChinaEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, ChinaEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, ChinaEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, ChinaEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, ChinaEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, ChinaEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, ChinaEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, ChinaEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, ChinaEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, ChinaEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, ChinaEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, ChinaThe First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, ChinaPurpose. To investigate the efficacy and safety of combined vitrectomy with tumor resection in the treatment of retinal vasoproliferative tumors (RVPT). Methods. Retrospective study. RVPT patients who underwent vitreous surgery at the Eye Hospital of Wenzhou Medical University from January 2011 to July 2017 were included. The main outcomes included treatment type, tumor activity, and best-corrected visual acuity (BCVA). Results. Altogether, 16 patients with 17 eyes were enrolled with follow-up of no less than 6 months. Eight eyes were in the resection treatment group (Group R) and 9 eyes were in the conservative treatment group (Group C). Female (69%) were more common. The mean age was 50 (49.72 ± 12.92) years. Fifteen patients got unilateral onset and only one patient suffered bilaterally. The common symptoms were decreased visual acuity, floaters, and visual distortion. The preoperative BCVA ranged from hand movement to 20/20, with an average of 0.82 ± 0.75 LogMAR. Patients were all not high myopia, with a mean axial length of 23.27 ± 0.27 mm (21.61 mm to 24.67 mm). Of the retinal diseases, the epiretinal membrane was the most common, followed by vitreous hemorrhage, uveitis, subretinal fluid, and so on. Compared with the baseline BCVA, it improved more at postoperative 6 months and the last visit in Group R than in Group C (P=0.006 and P=0.033). The BCVA-improved 0.2 LogMAR or above in 6 months was 2 eyes in Group C and 7 eyes in Group R. All tumors in Group R were completely resected, whereas three in Group C (33.3%) had definite activity (P=0.008). In all samples, tumors were located on the inner side of the retina and had small vessel wall thickening and hyaline degeneration. The degree of astrocyte proliferation varies widely among different tumors. Conclusions. RVPT was more likely to occur in nonhigh myopia patients. Epiretinal membrane and vitreous hemorrhage were the main causes for vitreous surgery in RVPT patients. Compared with conservative treatment, surgical resection of the tumor is more beneficial to patients on visual acuity recovery and preventing tumor relapse. It is a safe and effective way to treat RVPT.http://dx.doi.org/10.1155/2019/7464123
collection DOAJ
language English
format Article
sources DOAJ
author Bin Zheng
Yan Chen
Lifeng Chen
Huan Chen
Jingwei Zheng
Feng Chen
Zongming Song
Lin Fu
Xuting Hu
Jiandong Pan
Hengli Lian
Lijun Shen
Qiuming Li
spellingShingle Bin Zheng
Yan Chen
Lifeng Chen
Huan Chen
Jingwei Zheng
Feng Chen
Zongming Song
Lin Fu
Xuting Hu
Jiandong Pan
Hengli Lian
Lijun Shen
Qiuming Li
Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
Journal of Ophthalmology
author_facet Bin Zheng
Yan Chen
Lifeng Chen
Huan Chen
Jingwei Zheng
Feng Chen
Zongming Song
Lin Fu
Xuting Hu
Jiandong Pan
Hengli Lian
Lijun Shen
Qiuming Li
author_sort Bin Zheng
title Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
title_short Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
title_full Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
title_fullStr Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
title_full_unstemmed Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
title_sort comparative study on the efficacy and safety of tumor resection in vitrectomy for retinal vasoproliferative tumors
publisher Hindawi Limited
series Journal of Ophthalmology
issn 2090-004X
2090-0058
publishDate 2019-01-01
description Purpose. To investigate the efficacy and safety of combined vitrectomy with tumor resection in the treatment of retinal vasoproliferative tumors (RVPT). Methods. Retrospective study. RVPT patients who underwent vitreous surgery at the Eye Hospital of Wenzhou Medical University from January 2011 to July 2017 were included. The main outcomes included treatment type, tumor activity, and best-corrected visual acuity (BCVA). Results. Altogether, 16 patients with 17 eyes were enrolled with follow-up of no less than 6 months. Eight eyes were in the resection treatment group (Group R) and 9 eyes were in the conservative treatment group (Group C). Female (69%) were more common. The mean age was 50 (49.72 ± 12.92) years. Fifteen patients got unilateral onset and only one patient suffered bilaterally. The common symptoms were decreased visual acuity, floaters, and visual distortion. The preoperative BCVA ranged from hand movement to 20/20, with an average of 0.82 ± 0.75 LogMAR. Patients were all not high myopia, with a mean axial length of 23.27 ± 0.27 mm (21.61 mm to 24.67 mm). Of the retinal diseases, the epiretinal membrane was the most common, followed by vitreous hemorrhage, uveitis, subretinal fluid, and so on. Compared with the baseline BCVA, it improved more at postoperative 6 months and the last visit in Group R than in Group C (P=0.006 and P=0.033). The BCVA-improved 0.2 LogMAR or above in 6 months was 2 eyes in Group C and 7 eyes in Group R. All tumors in Group R were completely resected, whereas three in Group C (33.3%) had definite activity (P=0.008). In all samples, tumors were located on the inner side of the retina and had small vessel wall thickening and hyaline degeneration. The degree of astrocyte proliferation varies widely among different tumors. Conclusions. RVPT was more likely to occur in nonhigh myopia patients. Epiretinal membrane and vitreous hemorrhage were the main causes for vitreous surgery in RVPT patients. Compared with conservative treatment, surgical resection of the tumor is more beneficial to patients on visual acuity recovery and preventing tumor relapse. It is a safe and effective way to treat RVPT.
url http://dx.doi.org/10.1155/2019/7464123
work_keys_str_mv AT binzheng comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT yanchen comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT lifengchen comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT huanchen comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT jingweizheng comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT fengchen comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT zongmingsong comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT linfu comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT xutinghu comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT jiandongpan comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT henglilian comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT lijunshen comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT qiumingli comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
_version_ 1725112075483611136